Clinical evaluation of no-carrier-added meta- [123I]iodobenzylguanidine for myocardial scintigraphy

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 302-307

  Knickmeier, Markus ^a   Matheja, Peter ^a   Wichter, Thomas ^a   Schäfers, Klaus P ^a   Kies, Peter ^a   Breithardt, Günter ^a   Schober, Otmar ^a   Schäfers, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Heart; No carrier added MIBG; Presynaptic sympathetic innervation; Single photon emission tomography; Tachyarrhythmias

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART MUSCLE; HUMAN; IMAGE QUALITY; MALE; QUANTITATIVE ASSAY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TACHYCARDIA;

EID: 0034068212     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050037     Document Type: Article

References (20)

1. Schäfers M, Schober O, Lerch H. Cardiac sympathetic neurotransmission scintigraphy. Eur J Nucl Med 1998; 25: 435-441.
2. Matheja P, Schäfers M, Weckesser M, Wichter T, Schober O. Imaging sympathetic innervation. Q J Nucl Med 1999; 43: 281-290.
3. Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981; 22: 129-132.
4. De Marco T, Dae M, Yuen-Green MS, et al. Iodine-123 meta-iodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol 1995; 25: 927-931.
5. Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93: 1667-1676.
6. Sisson JC, Shapiro B, Meyers L, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28: 1625-1636.
7. Schäfers M, Wichter T, Lerch H, et al. Cardiac [I-123]meta-iodobenzylguanidine uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 1999; 40: 1-5.
8. Wichter T, Hindricks G, Lerch H, et al. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using [I-123]meta-iodobenzylguanidine scintigraphy. Circulation 1994; 89: 667-683.
9. Somsen GA, Borm JJ, Dubois EA, Schook MB, Van Der Wall EE, Van Royen EA. Cardiac [I-123]MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies. Nucl Med Commun 1996; 17: 872-876.
10. Franceschini R, Pecorale A, Chinol M, Calcagni ML, Servidei T, Riccardi R, Troncone L. In vitro and in vivo studies with no-carrier added radioiodinated MIBG. Q J Nucl Med 1995; 39: 72-77.
11. Vaidyanathan G, Zalutsky MR. No-carrier-added meta-[I-123]iodobenzylguanidine: synthesis and preliminary evaluation. Nucl Med Biol 1995; 22: 61-64.
12. Samnick S, Bader JB, Muller M, et al. Improved labelling of no-carrier-added [I-123]MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias. Nucl Med Commun 1999; 20: 537-545.
13. 131I]iodobenzylguanidine. Appl Radiat Isot 1993; 44: 621-628.
14. Solanki KK, Bomanji J, Moyes J. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992; 13: 513-521.
15. Schäfers M, Dutka D, Rhodes CG, et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 1998; 82: 57-62.
16. Schäfers M, Lerch H, Wichter T, et al. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 1998; 32: 181-186.
17. Mairs RJ, Cunningham SH, Russell J, et al. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation. J Nucl Med 1995; 36: 1088-1095.
18. Farahati J, Bier D, Scheubeck M, et al. Effect of specific activity on cardiac uptake of iodine-123-MIBG. J Nucl Med 1997; 38: 447-451.
19. Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993; 22: 368-375.
20. Dae MW, O'Connell JW, Botvinick EH, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 1995; 30: 270-280.